Allergan, Inc. (AGN) Tops Q3 EPS by 2c; Guides Q4 Below, FY11 In-Line
Tweet
Share
E-mailGet Alerts AGN Hot Sheet
Price: $193.02 --0%
Financial Fact:
Restructuring charges: 185.5M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Restructuring charges: 185.5M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Allergan, Inc. (NYSE: AGN) reported Q3 EPS of $0.92, $0.02 better than the analyst estimate of $0.90. Revenue for the quarter came in at $1.31 billion versus the consensus estimate of $1.33 billion.
Allergan, Inc. sees FY2011 EPS of $3.62-$3.64, versus the consensus of $3.64. Allergan, Inc. sees FY2011 revenue of $5.295-$5.390 billion, versus the consensus of $5.42 billion.
Allergan, Inc. sees Q4 2011 EPS of $0.97-$0.99, versus the consensus of $1.01. Allergan, Inc. sees Q4 2011 revenue of $1.330-$1.405 billion, versus the consensus of $1.41 billion.
Allergan, Inc. sees FY2011 EPS of $3.62-$3.64, versus the consensus of $3.64. Allergan, Inc. sees FY2011 revenue of $5.295-$5.390 billion, versus the consensus of $5.42 billion.
Allergan, Inc. sees Q4 2011 EPS of $0.97-$0.99, versus the consensus of $1.01. Allergan, Inc. sees Q4 2011 revenue of $1.330-$1.405 billion, versus the consensus of $1.41 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
